Home
ANIP
ANIP News

Latest ANI Pharmaceuticals Inc. (ANIP) News on June 18, 2025

3 of Wall Street’s Favorite Stocks with Questionable Fundamentals

StockStory

2 days ago

3 of Wall Street’s Favorite Stocks with Questionable Fundamentals

ANI Pharmaceuticals Announces Presentation of New Preclinical Data

GlobeNewswire

6 days ago

ANI Pharmaceuticals Announces Presentation of New Preclinical Data

3 Healthcare Stocks with Mounting Challenges

StockStory

6 days ago

3 Healthcare Stocks with Mounting Challenges

3 Cash-Producing Stocks in the Doghouse

StockStory

12 days ago

3 Cash-Producing Stocks in the Doghouse

ANIP Q1 CY2025 Earnings Call: Generics, Rare Disease Drive Growth; Retina Headwinds Noted

StockStory

14 days ago

ANIP Q1 CY2025 Earnings Call: Generics, Rare Disease Drive Growth; Retina Headwinds Noted

ANI Pharmaceuticals to Present at the 2025 Jefferies Global Healthcare Conference

GlobeNewswire

22 days ago

ANI Pharmaceuticals to Present at the 2025 Jefferies Global Healthcare Conference

3 Reasons to Avoid ANIP and 1 Stock to Buy Instead

StockStory

23 days ago

3 Reasons to Avoid ANIP and 1 Stock to Buy Instead

ANI Pharmaceuticals initiates Phase IV trial of gel for acute gout flares

Clinical Trials Arena

a month ago

ANI Pharmaceuticals initiates Phase IV trial of gel for acute gout flares

1 Russell 2000 Stock with Solid Fundamentals and 2 to Steer Clear Of

StockStory

a month ago

1 Russell 2000 Stock with Solid Fundamentals and 2 to Steer Clear Of

Generic Pharmaceuticals Stocks Q1 In Review: Amphastar Pharmaceuticals (NASDAQ:AMPH) Vs Peers

StockStory

a month ago

Generic Pharmaceuticals Stocks Q1 In Review: Amphastar Pharmaceuticals (NASDAQ:AMPH) Vs Peers

MT Newswires

a month ago

ANI Pharmaceuticals Launches Phase 4 Trial of Cortrophin Gel for Acute Gout Flares

ANI Pharmaceuticals Announces Initiation of Phase 4 Clinical Trial of Purified Cortrophin® Gel for the Treatment of Acute Gout Flares

GlobeNewswire

a month ago

ANI Pharmaceuticals Announces Initiation of Phase 4 Clinical Trial of Purified Cortrophin® Gel for the Treatment of Acute Gout Flares

3 Value Stocks with Mounting Challenges

StockStory

a month ago

3 Value Stocks with Mounting Challenges

Argus Research

a month ago

ANIP: Lowering target price to $64.00

Pharmaceuticals Stocks Q1 In Review: Jazz Pharmaceuticals (NASDAQ:JAZZ) Vs Peers

StockStory

a month ago

Pharmaceuticals Stocks Q1 In Review: Jazz Pharmaceuticals (NASDAQ:JAZZ) Vs Peers

Argus Research

a month ago

ANIP: Lowering target price to $65.00

3 Small-Cap Stocks Walking a Fine Line

StockStory

a month ago

3 Small-Cap Stocks Walking a Fine Line

ANI Pharmaceuticals to Participate at the H.C. Wainwright 3rd Annual BioConnect Conference at NASDAQ

GlobeNewswire

a month ago

ANI Pharmaceuticals to Participate at the H.C. Wainwright 3rd Annual BioConnect Conference at NASDAQ

ANI (ANIP) is an Incredible Growth Stock: 3 Reasons Why

Zacks

a month ago

ANI (ANIP) is an Incredible Growth Stock: 3 Reasons Why

ANI Pharmaceuticals First Quarter 2025 Earnings: Beats Expectations

Simply Wall St.

a month ago

ANI Pharmaceuticals First Quarter 2025 Earnings: Beats Expectations

GuruFocus.com

a month ago

ANI Pharmaceuticals Inc (ANIP) Q1 2025 Earnings Call Highlights: Record Revenue and Strategic ...

Cortrophin Demand Is Soaring For ANI Pharma, CEO Says Well-Positioned To Mitigate Potential Tariff Impact

Benzinga

a month ago

Cortrophin Demand Is Soaring For ANI Pharma, CEO Says Well-Positioned To Mitigate Potential Tariff Impact

Is ANI Pharmaceuticals (ANIP) Outperforming Other Medical Stocks This Year?

Zacks

a month ago

Is ANI Pharmaceuticals (ANIP) Outperforming Other Medical Stocks This Year?

Compared to Estimates, ANI (ANIP) Q1 Earnings: A Look at Key Metrics

Zacks

a month ago

Compared to Estimates, ANI (ANIP) Q1 Earnings: A Look at Key Metrics

MT Newswires

a month ago

Sector Update: Health Care Stocks Flat to Higher Premarket Friday

MT Newswires

a month ago

Top Premarket Gainers

ANI Pharmaceuticals (ANIP) Tops Q1 Earnings and Revenue Estimates

Zacks

a month ago

ANI Pharmaceuticals (ANIP) Tops Q1 Earnings and Revenue Estimates

Associated Press Finance

a month ago

ANI: Q1 Earnings Snapshot

MT Newswires

a month ago

ANI Pharmaceuticals Q1 Adjusted Earnings, Revenue Rise; 2025 Outlook Raised

ANI Pharmaceuticals (NASDAQ:ANIP) Reports Strong Q1, Full-Year Outlook Slightly Exceeds Expectations

StockStory

a month ago

ANI Pharmaceuticals (NASDAQ:ANIP) Reports Strong Q1, Full-Year Outlook Slightly Exceeds Expectations

ANI Pharmaceuticals Reports Record First Quarter 2025 Financial Results and Raises 2025 Guidance

GlobeNewswire

a month ago

ANI Pharmaceuticals Reports Record First Quarter 2025 Financial Results and Raises 2025 Guidance

Pacira (PCRX) Q1 Earnings Surpass Estimates

Zacks

a month ago

Pacira (PCRX) Q1 Earnings Surpass Estimates

ANI Pharmaceuticals Inc (ANIP) Q1 2025: Everything You Need To Know Ahead Of Earnings

GuruFocus.com

a month ago

ANI Pharmaceuticals Inc (ANIP) Q1 2025: Everything You Need To Know Ahead Of Earnings

Earnings To Watch: ANI Pharmaceuticals (ANIP) Reports Q1 Results Tomorrow

StockStory

a month ago

Earnings To Watch: ANI Pharmaceuticals (ANIP) Reports Q1 Results Tomorrow

Argus Research

a month ago

ANIP: What does Argus have to say about ANIP?

ANI Pharmaceuticals to Report Q1 Earnings: Is a Beat in the Cards?

Zacks

a month ago

ANI Pharmaceuticals to Report Q1 Earnings: Is a Beat in the Cards?

ANI Pharmaceuticals, Inc. (ANIP) Hit a 52 Week High, Can the Run Continue?

Zacks

a month ago

ANI Pharmaceuticals, Inc. (ANIP) Hit a 52 Week High, Can the Run Continue?

ANI Pharmaceuticals Announces Presentation of Preclinical Data on the Use of Purified Cortrophin® Gel in an Experimental Autoimmune Uveitis (EAU) Mouse Model

GlobeNewswire

a month ago

ANI Pharmaceuticals Announces Presentation of Preclinical Data on the Use of Purified Cortrophin® Gel in an Experimental Autoimmune Uveitis (EAU) Mouse Model

ANI Pharmaceuticals (ANIP) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Zacks

2 months ago

ANI Pharmaceuticals (ANIP) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Generic Pharmaceuticals Stocks Q4 Teardown: Viatris (NASDAQ:VTRS) Vs The Rest

StockStory

2 months ago

Generic Pharmaceuticals Stocks Q4 Teardown: Viatris (NASDAQ:VTRS) Vs The Rest

1 of Wall Street’s Favorite Stock to Target This Week and 2 to Keep Off Your Radar

StockStory

2 months ago

1 of Wall Street’s Favorite Stock to Target This Week and 2 to Keep Off Your Radar

3 Reasons Growth Investors Will Love ANI (ANIP)

Zacks

2 months ago

3 Reasons Growth Investors Will Love ANI (ANIP)

How to Find Strong Medical Stocks Slated for Positive Earnings Surprises

Zacks

2 months ago

How to Find Strong Medical Stocks Slated for Positive Earnings Surprises

Will Pfizer's Non-COVID Drugs Drive Sales Again This Earnings Season?

Zacks

2 months ago

Will Pfizer's Non-COVID Drugs Drive Sales Again This Earnings Season?

Zacks.com featured highlights include Heritage Insurance, Marex, Kingstone, ANI Pharmaceuticals and HCI

Zacks

2 months ago

Zacks.com featured highlights include Heritage Insurance, Marex, Kingstone, ANI Pharmaceuticals and HCI

Are Medical Stocks Lagging ANI Pharmaceuticals (ANIP) This Year?

Zacks

2 months ago

Are Medical Stocks Lagging ANI Pharmaceuticals (ANIP) This Year?

Zacks.com featured highlights include ANI Pharmaceuticals, Heritage Insurance, Avista and Exelon

Zacks

2 months ago

Zacks.com featured highlights include ANI Pharmaceuticals, Heritage Insurance, Avista and Exelon

5 Stocks With Recent Price Strength Amid Tariff-Led Volatility

Zacks

2 months ago

5 Stocks With Recent Price Strength Amid Tariff-Led Volatility

Argus Research

2 months ago

ANIP: Lowering target price to $72.00

4 Stocks Trading Near 52-Week High With Room to Rise Further

Zacks

2 months ago

4 Stocks Trading Near 52-Week High With Room to Rise Further

MT Newswires

2 months ago

Truist Lifts Price Target on ANI Pharmaceuticals to $65 From $62, Keeps Hold Rating

ANI Pharmaceuticals, Inc. (ANIP) Soars to 52-Week High, Time to Cash Out?

Zacks

2 months ago

ANI Pharmaceuticals, Inc. (ANIP) Soars to 52-Week High, Time to Cash Out?

Pharmaceuticals Stocks Q4 In Review: Jazz Pharmaceuticals (NASDAQ:JAZZ) Vs Peers

StockStory

2 months ago

Pharmaceuticals Stocks Q4 In Review: Jazz Pharmaceuticals (NASDAQ:JAZZ) Vs Peers

Argus Research

2 months ago

ANIP: Raising target price to $73.00

ANI Pharmaceuticals (ANIP): Buy, Sell, or Hold Post Q4 Earnings?

StockStory

2 months ago

ANI Pharmaceuticals (ANIP): Buy, Sell, or Hold Post Q4 Earnings?

IBD 50 Stock Flashes 'Golden Cross' But Massive Risk Looms

Investor's Business Daily

2 months ago

IBD 50 Stock Flashes 'Golden Cross' But Massive Risk Looms

VALN Doses First Infant With Shigella Vaccine in Mid-Stage Study

Zacks

2 months ago

VALN Doses First Infant With Shigella Vaccine in Mid-Stage Study

3 Reasons Why Growth Investors Shouldn't Overlook ANI (ANIP)

Zacks

2 months ago

3 Reasons Why Growth Investors Shouldn't Overlook ANI (ANIP)

Will ANI (ANIP) Beat Estimates Again in Its Next Earnings Report?

Zacks

2 months ago

Will ANI (ANIP) Beat Estimates Again in Its Next Earnings Report?

These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar

Zacks

2 months ago

These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar

ANI Pharmaceuticals to Discuss First Quarter 2025 Financial Results on May 9, 2025, at 8:00 a.m. ET

GlobeNewswire

2 months ago

ANI Pharmaceuticals to Discuss First Quarter 2025 Financial Results on May 9, 2025, at 8:00 a.m. ET

Argus Research

2 months ago

ANIP: Lowering target price to $66.00

Zacks.com featured highlights ANI Pharmaceuticals, Expand Energy, Avista Corp and Contango ORE

Zacks

2 months ago

Zacks.com featured highlights ANI Pharmaceuticals, Expand Energy, Avista Corp and Contango ORE

Is ANI Pharmaceuticals (ANIP) Stock Outpacing Its Medical Peers This Year?

Zacks

2 months ago

Is ANI Pharmaceuticals (ANIP) Stock Outpacing Its Medical Peers This Year?

Tariff Woes? Play Safe With 4 Low-Beta Stocks: ANIP, EXE, AVA & CTGO

Zacks

2 months ago

Tariff Woes? Play Safe With 4 Low-Beta Stocks: ANIP, EXE, AVA & CTGO

Is the Options Market Predicting a Spike in ANI Pharmaceuticals (ANIP) Stock?

Zacks

2 months ago

Is the Options Market Predicting a Spike in ANI Pharmaceuticals (ANIP) Stock?

3 Russell 2000 Stocks in the Doghouse

StockStory

3 months ago

3 Russell 2000 Stocks in the Doghouse

Zacks.com featured highlights include HIS, ANI Pharmaceuticals, Pediatrix Medical, Fresenius Medical Care and LendingTree

Zacks

3 months ago

Zacks.com featured highlights include HIS, ANI Pharmaceuticals, Pediatrix Medical, Fresenius Medical Care and LendingTree

Argus Research

3 months ago

ANIP: Raising target price to $71.00

5 Relative Price Strength Stocks to Navigate Today's Market

Zacks

3 months ago

5 Relative Price Strength Stocks to Navigate Today's Market

ANI Pharmaceuticals to Present at 2025 RBC Capital Markets Ophthalmology Virtual Conference

GlobeNewswire

3 months ago

ANI Pharmaceuticals to Present at 2025 RBC Capital Markets Ophthalmology Virtual Conference

Argus Research

3 months ago

ANIP: Raising target price to $70.00

5 Top-Ranked Mid-Cap Stocks to Buy for a Stellar Portfolio

Zacks

3 months ago

5 Top-Ranked Mid-Cap Stocks to Buy for a Stellar Portfolio

Is ANI (ANIP) a Solid Growth Stock? 3 Reasons to Think "Yes"

Zacks

3 months ago

Is ANI (ANIP) a Solid Growth Stock? 3 Reasons to Think "Yes"

Wall Street Analysts Think ANI (ANIP) Could Surge 26.83%: Read This Before Placing a Bet

Zacks

3 months ago

Wall Street Analysts Think ANI (ANIP) Could Surge 26.83%: Read This Before Placing a Bet

Should You Buy ANI Pharmaceuticals (ANIP) After Golden Cross?

Zacks

3 months ago

Should You Buy ANI Pharmaceuticals (ANIP) After Golden Cross?

Is Corcept Therapeutics (CORT) Stock Outpacing Its Medical Peers This Year?

Zacks

3 months ago

Is Corcept Therapeutics (CORT) Stock Outpacing Its Medical Peers This Year?

MT Newswires

3 months ago

Ani Pharmaceuticals Launches Nitazoxanide Tablets for Treating Diarrhea

ANI Pharmaceuticals Announces the Launch of Nitazoxanide Tablets

GlobeNewswire

3 months ago

ANI Pharmaceuticals Announces the Launch of Nitazoxanide Tablets

Teva Pharmaceutical Stock Scores RS Rating Upgrade

Investor's Business Daily

3 months ago

Teva Pharmaceutical Stock Scores RS Rating Upgrade

MT Newswires

3 months ago

ANI Pharmaceuticals Completes Buyout of Royalty Obligation for Iluvien, Yutiq

ANI Pharmaceuticals Announces Buyout of Royalty Obligation for ILUVIEN® and YUTIQ®

GlobeNewswire

3 months ago

ANI Pharmaceuticals Announces Buyout of Royalty Obligation for ILUVIEN® and YUTIQ®

Q4 Earnings Roundup: Elanco (NYSE:ELAN) And The Rest Of The Pharmaceuticals Segment

StockStory

3 months ago

Q4 Earnings Roundup: Elanco (NYSE:ELAN) And The Rest Of The Pharmaceuticals Segment

MT Newswires

3 months ago

ANI Pharmaceuticals Says FDA Approves Expanded Label for Iluvien

MT Newswires

3 months ago

Jefferies Initiates Coverage on ANI Pharmaceuticals With Buy Rating, $80 Price Target

ANI Pharmaceuticals Announces FDA Approval for Expansion of ILUVIEN® Label

GlobeNewswire

3 months ago

ANI Pharmaceuticals Announces FDA Approval for Expansion of ILUVIEN® Label

Relative Price Strength: A Smart Strategy Amid Market Turmoil

Zacks

3 months ago

Relative Price Strength: A Smart Strategy Amid Market Turmoil

Q4 Earnings Highs And Lows: Amphastar Pharmaceuticals (NASDAQ:AMPH) Vs The Rest Of The Generic Pharmaceuticals Stocks

StockStory

3 months ago

Q4 Earnings Highs And Lows: Amphastar Pharmaceuticals (NASDAQ:AMPH) Vs The Rest Of The Generic Pharmaceuticals Stocks

BIIB Starts Felzartamab Phase III Study in AMR in Kidney Transplant

Zacks

3 months ago

BIIB Starts Felzartamab Phase III Study in AMR in Kidney Transplant

Zacks.com featured highlights include ANI Pharmaceuticals, Dana, Pitney Bowes, Priority Technology and Kingstone

Zacks

3 months ago

Zacks.com featured highlights include ANI Pharmaceuticals, Dana, Pitney Bowes, Priority Technology and Kingstone

1 Growth Stock to Target This Week and 2 to Avoid

StockStory

3 months ago

1 Growth Stock to Target This Week and 2 to Avoid

MT Newswires

3 months ago

JPMorgan Initiates ANI Pharmaceuticals at Overweight With $85 Price Target

MT Newswires

3 months ago

Ani Pharmaceuticals Insider Sold Shares Worth $323,049, According to a Recent SEC Filing

Wall Street Analysts Believe ANI (ANIP) Could Rally 32.4%: Here's is How to Trade

Zacks

3 months ago

Wall Street Analysts Believe ANI (ANIP) Could Rally 32.4%: Here's is How to Trade

ANI (ANIP) is an Incredible Growth Stock: 3 Reasons Why

Zacks

3 months ago

ANI (ANIP) is an Incredible Growth Stock: 3 Reasons Why

ANI (ANIP) Upgraded to Strong Buy: Here's What You Should Know

Zacks

3 months ago

ANI (ANIP) Upgraded to Strong Buy: Here's What You Should Know

Should Value Investors Buy ANI Pharmaceuticals (ANIP) Stock?

Zacks

3 months ago

Should Value Investors Buy ANI Pharmaceuticals (ANIP) Stock?

Has ANI Pharmaceuticals (ANIP) Outpaced Other Medical Stocks This Year?

Zacks

3 months ago

Has ANI Pharmaceuticals (ANIP) Outpaced Other Medical Stocks This Year?

Generic Pharmaceuticals Stocks Q4 In Review: Amneal (NASDAQ:AMRX) Vs Peers

StockStory

3 months ago

Generic Pharmaceuticals Stocks Q4 In Review: Amneal (NASDAQ:AMRX) Vs Peers

Argus Research

3 months ago

ANIP: Raising target price to $47.00

Share on Social Networks: